Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-03-20
1998-07-14
Feisee, Lila
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4242341, 435 7021, 4351722, 435340, 5303884, 5303895, A61K 39395, C07K 1528
Patent
active
057800308
ABSTRACT:
The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal anti-bodies and antigens.
REFERENCES:
patent: 5034515 (1991-07-01), Proctor
patent: 5523089 (1996-06-01), Bergstrom et al.
Schaible et al., Monoclonal antibodies specific for the outer surface pron A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (Scid mice), Proc. Natl. Acad. Sci. 82: 3768-3772 (May 1990).
Schaible et al., "The severe combined immunodeficiency (Scid) mouse," J. Exp. Med. 170: 1427-1432 (Oct. 1989).
Wallach et al., Evaluation of genetic divergence among Borrelia Burgdorferi isolates by use of OSPA, fla, MSP60, and MSP70 gene products, Infection and Immunity, 4856-4866 (Nov. 1992).
Benach et al., "Biological activity of Borrelia burgdorferi antigens," Ann. N.Y. Acad. Sci. 539: 115-125 (1988).
Craft et al., "Antigens of Borrelia burgdorferi recognized during Lyme disease," J. Clin. Immunol. 934-939 (Oct. 1986).
Alan C. Steere, "Lyme Disease," The New England Journal of Medicine, 586-595 (Aug. 31, 1986).
Simon et al., "A mouse model for Borrelia burgdorferi infection: -approach to a vaccine against Lyme disease", Immunology Today, vol. 12, No. 1, p. 11 (1991).
Schaible et al., "Monoclonal antibodies specific for the outer-surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice", Proc. Natl. Acad. Sci. USA, vol. 87, pp. 3768-3772, May 1990.
Fikrig et al., "Protection of Mice Against the Lyme Disease Agent-by Immunizing with Recombinant OspA", Science, p. 553, Oct. 1990.
Bergstrom et al., "Molecular Analysis of linear plasmid-encoded-major surface proteins, OspA and OspB, of the Lyme Disease spirochaete Borrelia burgdorferi", Molecular Microbiology, vol. 3, No. 4, pp. 479-486 (1989).
Lane et al., "Antigenic Characteristics of Borrelia burgdorferi-isolated from Ixodid Ticks in California", J. Clinical Microbiology, pp. 2344-2349, Oct. 1989.
Wallich et al., "Cloning and sequencing of the gene encoding-the outer surface protein A (OspA) of a European Borrelia burgdorferi isolate", Nucleic Acids Research, Nov. 1989.
Schaible et al., "Demonstration of Antigen-Specific T Cells and-Histophatological Alterations in Mice Experimentally Inoculated with Borrelia burgdorferi", pp. 41-47, Jan. 1989.
Johnson et al., "Experimental Infection of the Hamster with-Borrelia burgdorferi", Annals of the New York Academy of Sciences, p. 258 (1987).
Howe et al., "Organization of Genes Encoding Two Outer Membrane-Proteins in the Lyme Disease Agent Borrelia burgdorferi within a Single Transcription Unit", Infection and Immunity, p. 207, Oct. 1986.
Howe et al., "A Single Recombinant Plasmid Expressing Two Major-Outer Surface Proteins of the Lyme Disease Spirochete", Science, vol. 227 p. 645, Feb. 1985.
Barbour et al., "Heterogeneity of Major Proteins in Lyme Disease-Borrelia burgdorferi A Molecular Analysis of North American and European Isolates", J. Infectious Diseases, vol. 152, No. 3, p. 478, Sep. 1985.
Seaver 1994 Geretic Engineering, vol. 14(14): 10 and 21. Dorlands Pocket Medical Dictionary 22nd Ed. 1977 p. 696.
Howe et al 1986 Infection & Immunity vol. 54 (1): 207-212.
Wilske et al 1988 Annals NY Acad Sci vol. 539: 126-143.
Eichmann Klaus
Kramer Michael
Reinhard Wallich
Schaible Ulrich E.
Simon Markus M.
Deutsches Krebsforschun Zentrum Stiftung des Offentlichen Rechts
Feisee Lila
Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.v.
Reeves Julie E.
LandOfFree
Passive vaccine against Lyme disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Passive vaccine against Lyme disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Passive vaccine against Lyme disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1879243